Search Results - "Höfner, K."

Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability by Halaska, M, Ralph, G, Wiedemann, A, Primus, G, Ballering-Brühl, B, Höfner, K, Jonas, U

“…Our objectives were to ascertain the tolerability and efficacy of trospium chloride in doses of 20 mg twice daily for long-term therapy (52 weeks) in patients…”
Get full text

Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction by Höfner, K, Claes, H, De Reijke, T M, Folkestad, B, Speakman, M J

“…To evaluate the effect of tamsulosin, 0.4 mg once daily, on sexual function in comparison with placebo and alfuzosin, 2.5 mg three times daily, in patients…”
Get more information

Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia by Höfner, K., Burkart, M., Jacob, G., Jonas, U.

“…Objectives To investigate the symptomatic and quality of life (QoL) response to treatment with tolterodine extended release (ER) in subgroups of male patients…”
Get full text

The effects of combination therapy with dutasteride plus tamsulosin on clinical outcomes in men with symptomatic BPH: 4-year post hoc analysis of European men in the CombAT study by Haillot, O, Fraga, A, Maciukiewicz, P, Pushkar, D, Tammela, T, Höfner, K, Chantada, V, Gagnier, P, Morrill, B

“…CombAT (Combination of Avodart and Tamsulosin) was a randomised, double-blind study in men ( n =4844) aged ⩾50 years with a clinical diagnosis of BPH. Patients…”
Get full text

Safety and efficacy of tolterodine extended release in men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia by HÖFNER, K, BURKART, M, JACOB, G, JONAS, U

“…Patients with presumed non-obstructive BPH (Q (max )>or= 15 ml/s) treated with tolterodine ER 4 mg/day for OAB symptoms, alone or added to unsuccessful…”
Get full text

Male lower urinary tract symptoms and related health care seeking in Germany by Berges, R R, Pientka, L, Höfner, K, Senge, T, Jonas, U

“…To investigate the prevalence of lower urinary tract symptoms (LUTS) and LUTS- related health care issues in the male population between the ages of 50 and 80…”
Get more information

Trospium chloride--an effective drug in the treatment of overactive bladder and detrusor hyperreflexia by Höfner, K, Oelke, M, Machtens, S, Grünewald, V

“…Trospium chloride (TCL), a quaternary ammonium derivative of nortropanol, has been evaluated in a number of clinical and pharmacological studies. Selected…”
Get full text

Future drugs for the treatment of benign prostatic hyperplasia by ANDERSSON, Karl-Erik, CHAPPLE, C. R, HÖFNER, K

“…For at least a decade, no new drug principles have been added to the therapeutic armamentarium for the treatment of lower urinary tract symptoms (LUTS)…”
Get full text

High energy thermotherapy in the treatment of benign prostatic hyperplasia: results of the European Benign Prostatic Hyperplasia Study Group by de la Rosette, J J, de Wildt, M J, Höfner, K, Carter, S S, Debruyne, F M, Tubaro, A

“…We documented the results of high energy transurethral microwave thermotherapy in the treatment of benign prostatic hyperplasia. We evaluated 116 patients…”
Get more information

alpha(1)-Blocker therapy in the nineties: focus on the disease by Höfner, K

“…Therapy for benign prostatic hyperplasia has evolved rapidly over the last decade, with the introduction in the early 1990s of new agents such as…”
Get full text

Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation by Jonas, U., Höfner, K., Madersbacher, H., Holmdahl, T. H.

“…Tolterodine is a new competitive muscarinic receptor antagonist developed for the treatment of the unstable bladder. A total of 242 patients were enrolled in a…”
Get full text

Symptom scores, watchful waiting and prostate specific antigen levels in benign prostatic hyperplasia by Jonas, U, Höfner, K

Get more information

Transurethral microwave thermotherapy by Lynch, J H, Höfner, K

“…The present status of transurethral microwave thermotherapy (TUMT) in the low (LE) and high energy (HE) version is given as an overview. With LE software,…”
Get more information

Pressure-flow study analyses in patients treated with high energy thermotherapy by de la Rosette, J J, de Wildt, M J, Höfner, K, Carter, S S, Debruyne, F M, Tubaro, A

“…We evaluated the urodynamic changes after high energy microwave thermotherapy in patients with lower urinary tract symptoms and benign prostatic enlargement. A…”
Get more information

p53 overexpression as a prognostic factor for advanced stage bladder cancer by Kuczyk, M.A., Bokemeyer, C., Serth, J., Hervatin, C., Oelke, M., Höfner, K., Tan, H.K., Jonas, U.

“…Overexpression of the TP53 gene protein detected by immunohistochemistry appears to identify those patients with superficial bladder cancer at risk of the…”
Get full text

Hartnäckige Mythen zum Thema BPS – und was davon wirklich stimmt by Oelke, M., Bschleipfer, T., Höfner, K.

“…Zusammenfassung Hintergrund Das benigne Prostatasyndrom (BPS) ist die vierthäufigste und fünfteuerste Erkrankung von Männern ≥50 Jahre. Obwohl die meisten…”
Get full text

Replantation of the complete external genitals by BECKER, M, HÖFNER, K, LASSNER, F, PALLUA, N, BERGER, A

“…Most cases of genital amputation represent an isolated penile amputation; the combined amputation of both penile and testes is reported very seldom. We…”
Get full text

Historical aspects of the treatment of urinary incontinence by Schultheiss, D, Höfner, K, Oelke, M, Grünewald, V, Jonas, U

“…Ancient reports on urinary incontinence are rather rare and mainly address cases of extraurethral incontinence, e.g. due to a fistula acquired during…”
Get more information

Responders and nonresponders to transurethral microwave thermotherapy: a multicenter retrospective analysis by de Wildt, M J, Tubaro, A, Höfner, K, Carter, S S, de la Rosette, J J, Devonec, M

“…We attempted to identify any parameter that could possibly lead to a successful treatment outcome after transurethral microwave thermotherapy. Clinical…”
Get more information

A placebo‐controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence by MADERSBACHER, H, HALASKA, M, VOIGT, R, ALLOUSSI, S, HÖFNER, K

“…Objective  To assess the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence in a randomized, double‐blind…”
Get full text